BiVictriX Therapeutics PLC (GB:BVX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BiVictriX Therapeutics PLC announces the cessation of trading its shares on the AIM market as of September 10, 2024, transitioning to a private company under the new name BiVictriX Therapeutics Limited. Shareholders can still trade shares via the JP Jenkins matched bargain facility, effective for at least six months post-cancellation. The company continues its development of innovative cancer therapies and encourages shareholders to stay informed through its website or LinkedIn updates.
For further insights into GB:BVX stock, check out TipRanks’ Stock Analysis page.
